These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 16384988

  • 1. Ocular changes after photodynamic therapy.
    Tzekov R, Lin T, Zhang KM, Jackson B, Oyejide A, Orilla W, Kulkarni AD, Kuppermann BD, Wheeler L, Burke J.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):377-85. PubMed ID: 16384988
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
    Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS.
    Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with Verteporfin.
    Soucek P, Cihelková I.
    Neuro Endocrinol Lett; 2004 Jul; 25(1-2):109-14. PubMed ID: 15159693
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
    Schlötzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U.
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
    Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA.
    Retina; 2001 Sep; 21(5):493-8. PubMed ID: 11642379
    [Abstract] [Full Text] [Related]

  • 12. Multifocal electroretinograms in age-related macular degeneration before and after photodynamic therapy.
    Kojima M, Yukawa E, Shimoyama K, Nochioka K, Tsujinaka H, Matsuura T.
    Eur J Ophthalmol; 2012 Sep; 22(3):412-6. PubMed ID: 21928263
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.
    Kim IK, Husain D, Michaud N, Connolly E, Lane AM, Durrani K, Hafezi-Moghadam A, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):357-63. PubMed ID: 16384985
    [Abstract] [Full Text] [Related]

  • 14. Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy.
    Ishikawa K, Kondo M, Ito Y, Kikuchi M, Nishihara H, Piao CH, Sugita T, Terasaki H.
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2254-9. PubMed ID: 17460288
    [Abstract] [Full Text] [Related]

  • 15. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
    Yodoi Y, Tsujikawa A, Kameda T, Otani A, Tamura H, Mandai M, Yoshimura N.
    Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
    [Abstract] [Full Text] [Related]

  • 16. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM, Michels S.
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [Abstract] [Full Text] [Related]

  • 17. Choroidal and Retinal Changes After Systemic Adrenaline and Photodynamic Therapy in Non-Human Primates.
    Cheong KX, Barathi VA, Teo KYC, Chakravarthy U, Tun SBB, Busoy JM, Ho CEH, Agrawal R, Takahashi K, Cheung CMG.
    Invest Ophthalmol Vis Sci; 2021 Mar 01; 62(3):25. PubMed ID: 33729474
    [Abstract] [Full Text] [Related]

  • 18. Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia.
    Ohno-Matsui K, Moriyama M, Hayashi K, Mochizuki M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct 01; 244(10):1363-6. PubMed ID: 16523294
    [Abstract] [Full Text] [Related]

  • 19. Influence of treatment parameters on selectivity of verteporfin therapy.
    Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2006 Jan 01; 47(1):371-6. PubMed ID: 16384987
    [Abstract] [Full Text] [Related]

  • 20. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
    Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N.
    Am J Ophthalmol; 2007 Jul 01; 144(1):7-14. PubMed ID: 17467649
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.